Klaria Pharma publishes prospectus for SEK 147.6 million rights issue

Klaria launched a unit issue of up to SEK 147.6 million, offering one unit right per share with four rights required per unit. Each unit includes four new shares and one free TO1 warrant; subscription price SEK 2.40 per unit, equal to SEK 0.60 per share. Subscription period runs Oct. 14-28, 2026; unit rights trade Oct. 14-23, 2026; BTU trading begins Oct. 14, 2026. TO1 warrants allow one new share at SEK 0.60 during set windows from Nov. 22-26, 2027 through Oct. 17-31, 2029. Commitments total SEK 111.1 million, covering 75.3% of the issue; non-participating shareholders face 50% dilution, rising to 55.6% if warrants exercised. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein. (C)